Myosana Therapeutics Inc. — Form D

Myosana Therapeutics Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-07. The offering totals $6.4M, of which $6.4M was reported sold. Industry: Other.

Offering

• Filed: 2022-12-07
• Form: D
• Accession: 0001955277-22-000001
• Industry: Other
• Exemptions: 06b
• Total offering: $6.4M
• Amount sold: $6.4M
• Investors: 6
• Date of first sale: 2022-11-22
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-466765

Issuer

• Name: Myosana Therapeutics Inc.
• CIK: 0001955277
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 8502 30TH AVE NW, SEATTLE, WA, 98117
• Phone: 206-465-3004

Officers, directors & promoters (8)

More

• CIK 1955277 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search